Watch Ticker

Reviva Pharmaceuticals Holdings, Inc. Common Stock

Go to Reviva Pharmaceuticals Holdings, Inc. Common Stock Website

$0.45

-0.01 (-1.66%)

Live

Previous Close

$0.4564

Day Range

$0.4375 - $0.469799

Previous Day Range

$0.4323 - $0.4585

Market Cap

$31.1 million USD

Day Vol.

813350

Previous Day Vol.

1.2 million

Currency

USD

Primary Exchange

Nasdaq

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and ca...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Delveinsight - Schizophrenia Market to Witness Significant Growth by 2034 Across 7MM as New Therapies Enter Late-Stage Trials | DelveInsight

The schizophrenia market is expected to grow significantly by 2034, driven by rising disease prevalence, expanding approved therapies, and the anticipated launch of new treatments such as Olanzapine LAI, Iclepertin, Ulotaront, and Brilaroxazine.

Related tickers: TEVA, RVPH, RVPHW, NERV.

Read Full Article

N/A - Reviva to Participate in the 2025 BIO CEO & Investor Conference

Reviva Pharmaceuticals Holdings, Inc. (RVPH), a late-stage pharmaceutical company, announced that its Founder, President, and CEO will participate in a panel discussion at the 2025 BIO CEO & Investor Conference, focusing on tackling mental health through new targets and endpoints progress.

Related tickers: RVPH, RVPHW.

Read Full Article

Trending Tickers

Please sign in to view